American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. …
Full AONCW analysis →
Competitive advantage assessment
Key strengths
Margins Stable Across CyclesOperating margin volatility is low (stability score 0.78), demonstrating pricing resilience across cycles.
Strong Liquidity BufferLiquidity position is strong (score 0.64), providing operational cushion.
Key risks
ROIC Below WACC or PeersROIC at 20.8th percentile suggests inefficient capital deployment.
American Oncology Network, Inc. ranks #38 of 58
scored companies in Medical Care Facilities by moat score — the top 66%.
The widest moat in the group is Encompass Health Corporation (EHC)
at 77/100.
Moat scores for companies ranked near AONCW in Medical Care Facilities
How AONCW scores on the Corporate Default defenses
Pricing Power
Score 38
· 20% of the moat score
Pricing power is the ability to raise prices without losing volume.
Cost Advantage
Score 60
· 15% of the moat score
A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.
Customer Stickiness
Score 33
· 15% of the moat score
Stickiness is what makes revenue repeat without being re-won every year.
Capital Efficiency
Score 25
· 18% of the moat score
Capital efficiency asks what the company earns on the money tied up in the business.
Resilience
Score 33
· 17% of the moat score
Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.
Scale & Market Position
Score 29
· 15% of the moat score
Scale matters only when it converts into economics.
What is American Oncology Network, Inc.'s moat score?
American Oncology Network, Inc. (AONCW) scores 36 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #38 of 58 scored companies in Medical Care Facilities, the top 66%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 57 companies in Medical Care Facilities. Its strongest defense is Cost Advantage (60/100) and its weakest is Capital Efficiency (25/100).
How does American Oncology Network, Inc. compare with other Medical Care Facilities companies?
American Oncology Network, Inc. ranks #38 of 58 scored companies in Medical Care Facilities by moat score. The widest moat in Medical Care Facilities is Encompass Health Corporation (EHC) at 77/100. The companies ranked closest are American Oncology Network, Inc. (AONC) at 36 just above it and AMN Healthcare Services Inc (AMN) at 33 just below it.
How is the moat score calculated?
Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 57 companies in Medical Care Facilities. The defenses are then weighted to produce the overall score out of 100.
Why is American Oncology Network, Inc. scored with the Corporate Default template?
Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.
Which competitive defenses are measured for American Oncology Network, Inc.?
The Corporate Default template measures 6 defenses, and AONCW scores: Pricing Power (38), Cost Advantage (60), Customer Stickiness (33), Capital Efficiency (25), Resilience (33), Scale & Market Position (29). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.
We value your privacy
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking 'Accept All', you consent to our use of cookies.
Read our cookie policy
Cookie Preferences
Manage your cookie preferences. Essential cookies are always enabled.